---
title: "Vedolizumab - Crohn's disease"
sidebar: mydoc_sidebar
permalink: db09033-mesh-d003424-1.html
toc: false 
---


Path ID: `DB09033_MESH_D003424_1`
{% include image.html url="images/db09033-mesh-d003424-1.png" file="db09033-mesh-d003424-1.png" alt="db09033-mesh-d003424-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C543529 | Vedolizumab | Drug |
| UniProt:P13612 | Integrin alpha-4 | Protein |
| UniProt:P26010 | Integrin beta-7 | Protein |
| UniProt:Q13477 | Mucosal addressin cell adhesion molecule 1 | Protein |
| GO:0072676 | Lymphocyte migration | BiologicalProcess |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D003424 | Crohn's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Vedolizumab | DECREASES ACTIVITY OF | Integrin Alpha-4 |
| Vedolizumab | DECREASES ACTIVITY OF | Integrin Beta-7 |
| Integrin Alpha-4 | POSITIVELY REGULATES | Mucosal Addressin Cell Adhesion Molecule 1 |
| Integrin Beta-7 | POSITIVELY REGULATES | Mucosal Addressin Cell Adhesion Molecule 1 |
| Mucosal Addressin Cell Adhesion Molecule 1 | POSITIVELY REGULATES | Lymphocyte Migration |
| Mucosal Addressin Cell Adhesion Molecule 1 | POSITIVELY REGULATES | Inflammatory Response |
| Lymphocyte Migration | POSITIVELY CORRELATED WITH | Crohn'S Disease |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Crohn'S Disease |
|---------|-----------|---------|

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/25952593/](https://pubmed.ncbi.nlm.nih.gov/25952593/)
  - [https://go.drugbank.com/drugs/DB09033#BE0000590](https://go.drugbank.com/drugs/DB09033#BE0000590)
